1Kumar R.Vitamin D metabolism and mechanisms of calcium transport.J Am Soc Nephrol,1990,1:30-42.
2Lanting L,May Ng,Anthony ML,et al.Vitamin D receptor gene expression in mammalian kidney.J Am Soc Nephrol,1994,5:1251-1258.
3Kurt L,Romain P,Jean-Paul C,et al.1,25-(OH) 2-16ene-23yne-D3 reduces secondary hyperparathyroidism in uremic rats with little calcemic effect.Hormone research,2004,61:7 -16.
4Andress DL.Vitamin D in chronic kidney disease:A systemic role for selective vitamin D receptor activation.Kidney Int,2006,69:33 -43.
5Li AC,Glass CK.The macrophage foam cell as a target for therapeutic intervention.Nat Med.2002,8:1235 -1242.
6Stenvinkel P,Ketteler M,Johnson RJ,et al.IL-10,IL-6,and TNF-alpha:central factors in the altered cytokine network of uremia--the good,the bad,and the ugly.Kidney Int,2005,67 (4):1216-1233.
7Teng M,Wolf M,Ofsthun MN,et al.Activated injectable vitamin D and hemodialysis survival:A historical cohort Study.J Am soc Nephrol,2005,16,1115-1125.
8Tetsuo S,Kayo S,Eiji K,et al.Lower risk for cardiovascular mortality in oral 1-hydroxy vitamin D3 users in a haemodialysis population.Nephrol dial Transplant,2004,19,179-184.
913th International Congress on Nutrition and Meytabolism in Renal Disease.Merida,Mexico,Feb,2006.
10Hariharan S,Hong S Y,Hsu A,et al.Effct of 1,25-dihydroxyvitamin D3 on mesangial cell proliferation.J Lab Clin Med,1991,117 (5):423-429.
